Literature DB >> 12665672

Parkin's substrates and the pathways leading to neuronal damage.

Mark R Cookson1.   

Abstract

Mutations in the Parkin gene are associated with Parkinson s disease (PD). The gene product has been shown to be an E3 protein-ubiquitin ligase, catalyzing the addition of ubiquitin to target proteins prior to their destruction via the proteasome. This activity is thus key in regulating the turnover of substrate proteins. A predictive hypothesis for how this results in PD is that the misregulation of proteasomal degradation of Parkin s substrates is deleterious to neurons. Several different laboratories have identified alternate candidate proteins. In this review, the likelihood of each of the proposed substrates for parkin being robust will be evaluated. The distribution and abundance of the proteins will be examined for clues as to which are the pathologically important substrates for parkin. The possibility that loss of regulation of turnover of one or more of these substrates contributes to the selective neurodegeneration seen in PD is also discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12665672     DOI: 10.1385/NMM:3:1:1

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   4.103


  69 in total

1.  Clinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations.

Authors:  B P van de Warrenburg; M Lammens; C B Lücking; P Denèfle; P Wesseling; J Booij; P Praamstra; N Quinn; A Brice; M W Horstink
Journal:  Neurology       Date:  2001-02-27       Impact factor: 9.910

Review 2.  Evolution and function of ubiquitin-like protein-conjugation systems.

Authors:  M Hochstrasser
Journal:  Nat Cell Biol       Date:  2000-08       Impact factor: 28.824

3.  Cell biology. Ubiquitin lives up to its name.

Authors:  Jean Marx
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

4.  U box proteins as a new family of ubiquitin-protein ligases.

Authors:  S Hatakeyama; M Yada; M Matsumoto; N Ishida; K I Nakayama
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

5.  The ubiquitin pathway in Parkinson's disease.

Authors:  E Leroy; R Boyer; G Auburger; B Leube; G Ulm; E Mezey; G Harta; M J Brownstein; S Jonnalagada; T Chernova; A Dehejia; C Lavedan; T Gasser; P J Steinbach; K D Wilkinson; M H Polymeropoulos
Journal:  Nature       Date:  1998-10-01       Impact factor: 49.962

6.  Visualization of prosomes (MCP-proteasomes), intermediate filament and actin networks by "instantaneous fixation" preserving the cytoskeleton.

Authors:  C Arcangeletti; R Sütterlin; U Aebi; F De Conto; S Missorini; C Chezzi; K Scherrer
Journal:  J Struct Biol       Date:  1997-06       Impact factor: 2.867

7.  E3 ubiquitin-protein ligase activity of Parkin is dependent on cooperative interaction of RING finger (TRIAD) elements.

Authors:  C A Rankin; C A Joazeiro; E Floor; T Hunter
Journal:  J Biomed Sci       Date:  2001-09       Impact factor: 8.410

8.  Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain.

Authors:  Lara Fallon; France Moreau; Benjamin G Croft; Noura Labib; Wen-Jie Gu; Edward A Fon
Journal:  J Biol Chem       Date:  2001-10-25       Impact factor: 5.157

9.  Synphilin-1 is present in Lewy bodies in Parkinson's disease.

Authors:  K Wakabayashi; S Engelender; M Yoshimoto; S Tsuji; C A Ross; H Takahashi
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

10.  CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity.

Authors:  Yuzuru Imai; Mariko Soda; Shigetsugu Hatakeyama; Takumi Akagi; Tsutomu Hashikawa; Kei Ichi Nakayama; Ryosuke Takahashi
Journal:  Mol Cell       Date:  2002-07       Impact factor: 17.970

View more
  21 in total

1.  Parkin transcript variants in rat and human brain.

Authors:  Velia Dagata; Sebastiano Cavallaro
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

Review 2.  Parkin plays a role in sporadic Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Neurodegener Dis       Date:  2013-09-11       Impact factor: 2.977

3.  Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.

Authors:  Anna Sandebring; Nodi Dehvari; Monica Perez-Manso; Kelly Jean Thomas; Elena Karpilovski; Mark R Cookson; Richard F Cowburn; Angel Cedazo-Mínguez
Journal:  FEBS J       Date:  2009-08-03       Impact factor: 5.542

4.  Carnosic Acid Attenuates 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells by Inducing Autophagy Through an Enhanced Interaction of Parkin and Beclin1.

Authors:  Chia-Yuan Lin; Chia-Wen Tsai
Journal:  Mol Neurobiol       Date:  2016-03-25       Impact factor: 5.590

5.  Accumulation of the authentic parkin substrate aminoacyl-tRNA synthetase cofactor, p38/JTV-1, leads to catecholaminergic cell death.

Authors:  Han Seok Ko; Rainer von Coelln; Sathya R Sriram; Seong Who Kim; Kenny K K Chung; Olga Pletnikova; Juan Troncoso; Brett Johnson; Roya Saffary; Eyleen L Goh; Hongjun Song; Bum-Joon Park; Min Jung Kim; Sunghoon Kim; Valina L Dawson; Ted M Dawson
Journal:  J Neurosci       Date:  2005-08-31       Impact factor: 6.167

6.  The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer.

Authors:  Yien Che Tsai; Allan M Weissman
Journal:  Genes Cancer       Date:  2010-07-01

7.  Mitochondrial dysfunction precedes other sub-cellular abnormalities in an in vitro model linked with cell death in Parkinson's disease.

Authors:  C J Yong-Kee; E Sidorova; A Hanif; G Perera; J E Nash
Journal:  Neurotox Res       Date:  2011-07-20       Impact factor: 3.911

8.  Lentiviral vector delivery of parkin prevents dopaminergic degeneration in an alpha-synuclein rat model of Parkinson's disease.

Authors:  Christophe Lo Bianco; Bernard L Schneider; Matthias Bauer; Ali Sajadi; Alexis Brice; Takeshi Iwatsubo; Patrick Aebischer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-02       Impact factor: 11.205

9.  Parkin loss leads to PARIS-dependent declines in mitochondrial mass and respiration.

Authors:  Daniel A Stevens; Yunjong Lee; Ho Chul Kang; Byoung Dae Lee; Yun-Il Lee; Aaron Bower; Haisong Jiang; Sung-Ung Kang; Shaida A Andrabi; Valina L Dawson; Joo-Ho Shin; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

10.  Parkin expression profile in dopamine d3 receptor knock-out mice brains.

Authors:  Velia D'Agata; Adriana Tiralongo; Alessandro Castorina; Gian Marco Leggio; Vincenzo Micale; Maria Luisa Carnazza; Filippo Drago
Journal:  Neurochem Res       Date:  2008-07-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.